Dashboard
Manage Tickers

EXAS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-maintains-overweight-on-exact-sciences-raises-price-target-to-70
Piper Sandler Maintains Overweight on Exac...
10/08/2025 12:40:35

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

evercore-isi-group-maintains-outperform-on-exact-sciences-raises-price-target-to-68
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:04:35

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target ...

exact-sciences-announces-publication-of-comparing-benefit-to-burden-ratios-of-endorsed-and-emerging-colorectal-cancer-screening-strategies-in-journal-of-national-cancer-institute
Exact Sciences Announces Publication Of Co...
10/07/2025 11:00:29

what-analysts-are-saying-about-exact-sciences-stock
What Analysts Are Saying About Exact Scien...
10/02/2025 19:01:38

barclays-maintains-overweight-on-exact-sciences-raises-price-target-to-65
Barclays Maintains Overweight on Exact Sci...
10/02/2025 13:56:58

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $55 ...

peering-into-exact-sciencess-recent-short-interest
Peering Into Exact Sciences's Recent Short...
09/18/2025 13:00:58

demystifying-exact-sciences-insights-from-9-analyst-reviews
Demystifying Exact Sciences: Insights From...
09/11/2025 22:02:07

craig-hallum-maintains-buy-on-exact-sciences-raises-price-target-to-85
Craig-Hallum Maintains Buy on Exact Scienc...
09/11/2025 17:21:22

Craig-Hallum analyst Alex Nowark maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $65 to $85.

exact-sciences-launches-cancerguard-test-a-new-multi-cancer-early-detection-blood-test-that-is-now-available-as-a-laboratory-developed-test-in-us-at-689
Exact Sciences Launches Cancerguard Test, ...
09/10/2025 10:40:51

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detectionOffered as a laboratory-develop...

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected
Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

micron-to-rally-more-than-49-here-are-10-top-analyst-forecasts-for-tuesday
Micron To Rally More Than 49%? Here Are 10...
08/12/2025 19:13:44

btig-maintains-buy-on-exact-sciences-lowers-price-target-to-60
BTIG Maintains Buy on Exact Sciences, Lowe...
08/12/2025 15:13:48

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $65 to $60.

beyond-the-numbers-7-analysts-discuss-exact-sciences-stock
Beyond The Numbers: 7 Analysts Discuss Exa...
08/11/2025 13:02:28

piper-sandler-maintains-overweight-on-exact-sciences-lowers-price-target-to-60
Piper Sandler Maintains Overweight on Exac...
08/11/2025 12:18:12

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and lowers the price target ...

top-3-health-care-stocks-that-are-preparing-to-pump-this-month
Top 3 Health Care Stocks That Are Preparin...
08/11/2025 12:01:23

evercore-isi-group-maintains-outperform-on-exact-sciences-lowers-price-target-to-64
Evercore ISI Group Maintains Outperform on...
08/08/2025 12:29:14

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...

exact-sciences-dip-a-chance-to-buy-as-freenome-deal-fortifies-future-analyst
Exact Sciences Dip A Chance To Buy As Free...
08/07/2025 18:56:41

Exact Sciences beat Q2 expectations, raised its 2025 forecast, and secured U.S. rights to Freenome's CRC blood tests in a m...

ubs-maintains-neutral-on-exact-sciences-lowers-price-target-to-53
UBS Maintains Neutral on Exact Sciences, L...
08/07/2025 17:28:15

UBS analyst Dan Leonard maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and lowers the price target from $61 to $53.

rbc-capital-maintains-sector-perform-on-exact-sciences-lowers-price-target-to-46
RBC Capital Maintains Sector Perform on Ex...
08/07/2025 14:56:24

RBC Capital analyst Conor McNamara maintains Exact Sciences (NASDAQ:EXAS) with a Sector Perform and lowers the price target ...

barclays-maintains-overweight-on-exact-sciences-lowers-price-target-to-55
Barclays Maintains Overweight on Exact Sci...
08/07/2025 13:22:30

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and lowers the price target from $65 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION